Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT07612137 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07612137
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-06-30
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.